drugset / Trial / NCT01931683

Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)

NCT01931683

Phase 4 Completed 27 enrolled Ajou University School of Medicine
NaSingle-groupDouble-blindTreatment

Summary

The investigators attempted to determine the optimal effect-site concentration of remifentanil for smooth removal of the LMA from propofol anesthesia.

Timeline

Start
2013-10
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 1 ng/ml

Indications